Why Medtronic (MDT) Stock Is Up Today

Medtronic (MDT) is up 4.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be continued momentum from Medtronic’s strong fiscal fourth-quarter report and a more constructive growth outlook for fiscal 2027. This could also be because investors are reacting to improving sentiment around the company’s cardiac ablation, robotics, and broader device portfolio after a recent analyst upgrade.

Details:

Medtronic’s June 3 fiscal fourth-quarter release showed revenue and adjusted earnings that came in ahead of expectations, with management highlighting its strongest annual revenue growth in about a decade.

The company guided for fiscal 2027 adjusted earnings per share of about $5.90 to $6.00 and pointed to continued momentum from higher-growth categories such as pulsed field ablation and other cardiovascular products.

Recent analyst commentary turned more positive, with at least one firm upgrading the stock to buy and arguing that product launches and improving organic growth could support higher estimates.

Medtronic also approved a higher quarterly dividend, which may have added to the positive tone around execution, cash generation, and shareholder returns.

Sources:

Medtronic, Investing.com, MarketBeat

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$MDT Insider Trading Activity

$MDT insiders have traded $MDT stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $MDT stock by insiders over the last 6 months:

HARRY SKIP KIIL (EVP & President Cardiovascular) has made 0 purchases and 7 sales selling 56,713 shares for an estimated $5,469,182.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$MDT Hedge Fund Activity

We have seen 963 institutional investors add shares of $MDT stock to their portfolio, and 1,003 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WCM INVESTMENT MANAGEMENT, LLC added 11,265,714 shares (+inf%) to their portfolio in Q1 2026, for an estimated $976,174,118
CAPITAL WORLD INVESTORS added 9,471,538 shares (+134.6%) to their portfolio in Q1 2026, for an estimated $820,708,767
BLACKROCK, INC. removed 7,355,311 shares (-6.1%) from their portfolio in Q1 2026, for an estimated $637,337,698
CAPITAL RESEARCH GLOBAL INVESTORS added 7,353,427 shares (+21.3%) to their portfolio in Q1 2026, for an estimated $637,174,449
WELLINGTON MANAGEMENT GROUP LLP removed 5,833,795 shares (-43.7%) from their portfolio in Q1 2026, for an estimated $505,498,336
BOSTON PARTNERS removed 4,707,978 shares (-69.9%) from their portfolio in Q1 2026, for an estimated $407,946,293
CITADEL ADVISORS LLC removed 4,246,447 shares (-81.2%) from their portfolio in Q1 2026, for an estimated $367,954,632

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$MDT Congressional Stock Trading

Members of Congress have traded $MDT stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $MDT stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/15.
REPRESENTATIVE KEVIN HERN sold up to $50,000 on 03/20.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$MDT Analyst Ratings

Wall Street analysts have issued reports on $MDT in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Needham issued a "Buy" rating on 02/17/2026
Barclays issued a "Overweight" rating on 01/08/2026
William Blair issued a "Outperform" rating on 01/06/2026

To track analyst ratings and price targets for $MDT, check out Quiver Quantitative's $MDT forecast page.

$MDT Price Targets

Multiple analysts have issued price targets for $MDT recently. We have seen 18 analysts offer price targets for $MDT in the last 6 months, with a median target of $100.5.

Here are some recent targets:

Mike Matson from Needham set a target price of $101.0 on 06/17/2026
Lee Hambright from Bernstein set a target price of $97.0 on 06/05/2026
David Roman from Goldman Sachs set a target price of $83.0 on 06/05/2026
David Rescott from Baird set a target price of $85.0 on 06/04/2026
Ryan Zimmerman from BTIG set a target price of $90.0 on 06/04/2026
Joshua Jennings from TD Cowen set a target price of $119.0 on 06/04/2026
Shagun Singh from RBC Capital set a target price of $118.0 on 06/04/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.